Literature DB >> 19157058

The role of biotransformation and bioactivation in toxicity.

Wolfgang Dekant1.   

Abstract

Biotransformation is essential to convert lipophilic chemicals to water-soluble and readily excretable metabolites. Formally, biotransformation reactions are classified into phase I and phase II reactions. Phase I reactions represent the introduction of functional groups, whereas phase II reactions are conjugations of such functional groups with endogenous, polar products. Biotransformation also plays an essential role in the toxicity of many chemicals due to the metabolic formation of toxic metabolites. These may be classified as stable but toxic products, reactive electrophiles, radicals, and reactive oxygen metabolites. The interaction of toxic products formed by biotransformation reactions with cellular macromolecules initiates the sequences resulting in cellular damage, cell death and toxicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19157058     DOI: 10.1007/978-3-7643-8336-7_3

Source DB:  PubMed          Journal:  EXS        ISSN: 1023-294X


  15 in total

Review 1.  Thinking outside the liver: induced pluripotent stem cells for hepatic applications.

Authors:  Mekala Subba Rao; Mitnala Sasikala; D Nageshwar Reddy
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

Review 2.  Advances in predictive in vitro models of drug-induced nephrotoxicity.

Authors:  Joanne Y-C Soo; Jitske Jansen; Rosalinde Masereeuw; Melissa H Little
Journal:  Nat Rev Nephrol       Date:  2018-06       Impact factor: 28.314

Review 3.  Improving the risk assessment of lipophilic persistent environmental chemicals in breast milk.

Authors:  Geniece M Lehmann; Marc-André Verner; Bryan Luukinen; Cara Henning; Sue Anne Assimon; Judy S LaKind; Eva D McLanahan; Linda J Phillips; Matthew H Davis; Christina M Powers; Erin P Hines; Sami Haddad; Matthew P Longnecker; Michael T Poulsen; David G Farrer; Satori A Marchitti; Yu-Mei Tan; Jeffrey C Swartout; Sharon K Sagiv; Clement Welsh; Jerry L Campbell; Warren G Foster; Raymond S H Yang; Suzanne E Fenton; Rogelio Tornero-Velez; Bettina M Francis; John B Barnett; Hisham A El-Masri; Jane Ellen Simmons
Journal:  Crit Rev Toxicol       Date:  2014-08       Impact factor: 5.635

4.  Metabolic Pathway Analysis and Effectiveness of Tamoxifen in Danish Breast Cancer Patients.

Authors:  Thomas P Ahern; Lindsay J Collin; James W Baurley; Anders Kjærsgaard; Rebecca Nash; Maret L Maliniak; Per Damkier; Michael E Zwick; R Benjamin Isett; Peer M Christiansen; Bent Ejlertsen; Kristina L Lauridsen; Kristina B Christensen; Rebecca A Silliman; Henrik Toft Sørensen; Trine Tramm; Stephen Hamilton-Dutoit; Timothy L Lash; Deirdre Cronin-Fenton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-01-13       Impact factor: 4.254

5.  Marinopyrrole A target elucidation by acyl dye transfer.

Authors:  Chambers C Hughes; Yu-Liang Yang; Wei-Ting Liu; Pieter C Dorrestein; James J La Clair; William Fenical
Journal:  J Am Chem Soc       Date:  2009-09-02       Impact factor: 15.419

Review 6.  Evaluating pharmacokinetic and pharmacodynamic interactions with computational models in supporting cumulative risk assessment.

Authors:  Yu-Mei Tan; Harvey Clewell; Jerry Campbell; Melvin Andersen
Journal:  Int J Environ Res Public Health       Date:  2011-05-19       Impact factor: 3.390

7.  Quantification of the Uncertainties in Extrapolating From In Vitro Androgen Receptor Antagonism to In Vivo Hershberger Assay Endpoints and Adverse Reproductive Development in Male Rats.

Authors:  Leon E Gray; Johnathan R Furr; Christy S Lambright; Nicola Evans; Phillip C Hartig; Mary C Cardon; Vickie S Wilson; Andrew K Hotchkiss; Justin M Conley
Journal:  Toxicol Sci       Date:  2020-08-01       Impact factor: 4.109

8.  Toxification of polycyclic aromatic hydrocarbons by commensal bacteria from human skin.

Authors:  Juliane Sowada; Lisa Lemoine; Karsten Schön; Christoph Hutzler; Andreas Luch; Tewes Tralau
Journal:  Arch Toxicol       Date:  2017-04-04       Impact factor: 5.153

9.  Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures.

Authors:  Andrew Baxter; Emmanuel Minet
Journal:  J Vis Exp       Date:  2017-03-28       Impact factor: 1.355

10.  Compensation for chronic oxidative stress in ALADIN null mice.

Authors:  Ramona Jühlen; Mirko Peitzsch; Sebastian Gärtner; Dana Landgraf; Graeme Eisenhofer; Angela Huebner; Katrin Koehler
Journal:  Biol Open       Date:  2018-01-23       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.